14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 3rd May 2024 ZNTL stock ended at $11.71. This is 5.40% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 5.76% from a day low at $11.45 to a day high of $12.11.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Zentalis Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Jul 19, 2023 $26.66 $26.86 $26.18 $26.39 293 289
Jul 18, 2023 $27.52 $27.55 $26.62 $26.65 550 322
Jul 17, 2023 $28.24 $28.43 $27.45 $27.51 389 276
Jul 14, 2023 $27.61 $28.14 $26.69 $28.12 391 461
Jul 13, 2023 $27.51 $28.21 $27.09 $27.63 544 604
Jul 12, 2023 $27.74 $27.84 $27.06 $27.27 280 903
Jul 11, 2023 $26.98 $27.41 $26.39 $27.33 346 065
Jul 10, 2023 $27.47 $27.71 $26.88 $27.05 533 156
Jul 07, 2023 $27.89 $28.24 $27.39 $27.56 263 287
Jul 06, 2023 $27.67 $28.07 $27.29 $27.86 255 234
Jul 05, 2023 $28.36 $28.66 $27.89 $27.98 286 700
Jul 03, 2023 $28.22 $29.03 $28.13 $28.29 259 833
Jun 30, 2023 $28.30 $28.33 $27.44 $28.21 559 776
Jun 29, 2023 $29.02 $29.40 $28.11 $28.13 594 257
Jun 28, 2023 $28.81 $29.42 $28.63 $29.00 533 601
Jun 27, 2023 $27.81 $29.01 $27.22 $28.99 697 090
Jun 26, 2023 $29.00 $29.24 $27.77 $27.81 646 203
Jun 23, 2023 $28.82 $29.54 $28.69 $29.00 955 051
Jun 22, 2023 $29.41 $29.59 $28.57 $28.99 983 340
Jun 21, 2023 $29.03 $30.51 $28.99 $29.66 2 150 160
Jun 20, 2023 $27.50 $28.61 $27.25 $28.52 1 459 867
Jun 16, 2023 $28.38 $28.42 $27.10 $27.62 2 205 219
Jun 15, 2023 $24.95 $28.19 $24.95 $27.75 1 966 087
Jun 14, 2023 $25.17 $25.59 $24.44 $24.63 465 198
Jun 13, 2023 $23.98 $25.42 $23.98 $25.14 674 783
Click to get the best stock tips daily for free!

About Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals. Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid tumors; Phase 1/2 clinical trial for the treatment of advanced solid tumors as a monotherapy and in an ... ZNTL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT